Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification

In Alzheimer's disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers. Several methods and platforms exist to measure those biomarkers, leading to challenges in combining data across studies. Thus, there is a need to...

Full description

Bibliographic Details
Main Authors: Jigyasha Timsina, Muhammad Ali, Anh Do, Lihua Wang, Daniel Western, Yun Ju Sung, Carlos Cruchaga
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996123003893
_version_ 1797364206372126720
author Jigyasha Timsina
Muhammad Ali
Anh Do
Lihua Wang
Daniel Western
Yun Ju Sung
Carlos Cruchaga
author_facet Jigyasha Timsina
Muhammad Ali
Anh Do
Lihua Wang
Daniel Western
Yun Ju Sung
Carlos Cruchaga
author_sort Jigyasha Timsina
collection DOAJ
description In Alzheimer's disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers. Several methods and platforms exist to measure those biomarkers, leading to challenges in combining data across studies. Thus, there is a need to identify methods that harmonize and standardize these values. We used a Z-score based approach to harmonize CSF and amyloid imaging data from multiple cohorts and compared GWAS results using this approach with currently accepted methods. We also used a generalized mixture model to calculate the threshold for biomarker-positivity.Based on our findings, our normalization approach performed as well as meta-analysis and did not lead to any spurious results. In terms of dichotomization, cutoffs calculated with this approach were very similar to those reported previously. These findings show that the Z-score based harmonization approach can be applied to heterogeneous platforms and provides biomarker cut-offs consistent with the classical approaches without requiring any additional data.
first_indexed 2024-03-08T16:31:58Z
format Article
id doaj.art-1632babe2c7c49be9046364be9fd5ae3
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-03-08T16:31:58Z
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-1632babe2c7c49be9046364be9fd5ae32024-01-06T04:38:26ZengElsevierNeurobiology of Disease1095-953X2024-01-01190106373Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classificationJigyasha Timsina0Muhammad Ali1Anh Do2Lihua Wang3Daniel Western4Yun Ju Sung5Carlos Cruchaga6Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USANeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO, USADepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Division of Biostatistics, Washington University School of Medicine, St. Louis, MO 63110, USADepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA; NeuroGenomics and Informatics Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Corresponding author at: Washington University School of Medicine, 4444 Forest Park Ave, St. Louis, MO 63110, USA.In Alzheimer's disease (AD) research, cerebrospinal fluid (CSF) Amyloid beta (Aβ), Tau and pTau are the most accepted and well validated biomarkers. Several methods and platforms exist to measure those biomarkers, leading to challenges in combining data across studies. Thus, there is a need to identify methods that harmonize and standardize these values. We used a Z-score based approach to harmonize CSF and amyloid imaging data from multiple cohorts and compared GWAS results using this approach with currently accepted methods. We also used a generalized mixture model to calculate the threshold for biomarker-positivity.Based on our findings, our normalization approach performed as well as meta-analysis and did not lead to any spurious results. In terms of dichotomization, cutoffs calculated with this approach were very similar to those reported previously. These findings show that the Z-score based harmonization approach can be applied to heterogeneous platforms and provides biomarker cut-offs consistent with the classical approaches without requiring any additional data.http://www.sciencedirect.com/science/article/pii/S0969996123003893HarmonizationZ-scoresBiomarkersImagingAlzheimer'sMeta-analysis
spellingShingle Jigyasha Timsina
Muhammad Ali
Anh Do
Lihua Wang
Daniel Western
Yun Ju Sung
Carlos Cruchaga
Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
Neurobiology of Disease
Harmonization
Z-scores
Biomarkers
Imaging
Alzheimer's
Meta-analysis
title Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
title_full Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
title_fullStr Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
title_full_unstemmed Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
title_short Harmonization of CSF and imaging biomarkers in Alzheimer's disease: Need and practical applications for genetics studies and preclinical classification
title_sort harmonization of csf and imaging biomarkers in alzheimer s disease need and practical applications for genetics studies and preclinical classification
topic Harmonization
Z-scores
Biomarkers
Imaging
Alzheimer's
Meta-analysis
url http://www.sciencedirect.com/science/article/pii/S0969996123003893
work_keys_str_mv AT jigyashatimsina harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT muhammadali harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT anhdo harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT lihuawang harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT danielwestern harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT yunjusung harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification
AT carloscruchaga harmonizationofcsfandimagingbiomarkersinalzheimersdiseaseneedandpracticalapplicationsforgeneticsstudiesandpreclinicalclassification